These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 5104542)
41. Interactions of TRIC agents with macrophages and BHK-21 cells observed by electron microscopy. Lawn AM; Blyth WA; Taverne J J Hyg (Lond); 1973 Sep; 71(3):515-28. PubMed ID: 4518351 [TBL] [Abstract][Full Text] [Related]
42. Latency in human infections with TRIC agents. Hanna L; Dawson CR; Briones O; Thygeson P; Jawetz E J Immunol; 1968 Jul; 101(1):43-50. PubMed ID: 4173937 [No Abstract] [Full Text] [Related]
43. [Characteristics and unknowns of TRIC agents (trachoma--inclusion conjunctivitis)]. Nabli B Rev Int Trach Pathol Ocul Trop Subtrop; 1980; 57(4):71-5. PubMed ID: 7280402 [No Abstract] [Full Text] [Related]
44. Virulence of trachoma-inclusion conjunctivitis agent after passage in baboons. Moore JE; Griffiths MS; Pearce JH Br J Exp Pathol; 1970 Jun; 51(3):298-304. PubMed ID: 4987927 [TBL] [Abstract][Full Text] [Related]
45. The syndrome known as Reiter's disease (a triad of polyarthritis, urethritis, and conjunctivitis). JACKSON WP Br Med J; 1946 Aug; 2():197-9. PubMed ID: 21065031 [No Abstract] [Full Text] [Related]
49. The biologic properties of TRIC agents isolated from human conjunctiva in South Australia. Howarth WH; Hardy D; Crompton DO; Surman PG Am J Ophthalmol; 1967 May; 63(5):Suppl:1041-4. PubMed ID: 4961060 [No Abstract] [Full Text] [Related]
50. Inclusion bodies in relation to TRIC agent infection. Hegab S Bull Ophthalmol Soc Egypt; 1971; 64(68):35-42. PubMed ID: 5154731 [No Abstract] [Full Text] [Related]
51. [The pathobiology of TRIC agents]. Jawetz E Rev Int Trach; 1973; 50(3):27-38. PubMed ID: 4780351 [No Abstract] [Full Text] [Related]
52. Complement-fixing antibodies to Bedsonia in Reiter's syndrome, TRIC agent infection, and control groups. Schachter J Am J Ophthalmol; 1971 Apr; 71(4):857-60. PubMed ID: 5553017 [No Abstract] [Full Text] [Related]
53. EXPERIMENTS IN HUMAN VOLUNTEERS WITH TRACHOMA AND INCLUSION CONJUNCTIVITIS AGENT. Mitsui Y; Konishi K; Nishimura A; Kajima M; Tamura O; Endo K Br J Ophthalmol; 1962 Nov; 46(11):651-9. PubMed ID: 18170828 [No Abstract] [Full Text] [Related]
54. Some consequences of the multiple infection of cell cultures by TRIC organisms. Blyth WA; Taverne J J Hyg (Lond); 1972 Mar; 70(1):33-7. PubMed ID: 4501841 [TBL] [Abstract][Full Text] [Related]
55. Advances and prospects in the study of certain diseases due to infections by subgroup A Chlamydia. Jones BR Br J Vener Dis; 1972 Feb; 48(1):13-7. PubMed ID: 4552586 [No Abstract] [Full Text] [Related]
56. Trachoma and inclusion conjunctivitis agents in the British Isles. Reeve P Mod Trends Med Virol; 1970; 2(0):186-203. PubMed ID: 5527957 [No Abstract] [Full Text] [Related]
57. GENITAL TRACHOMA. JONES BR Rev Int Trach; 1964; 41():425-38. PubMed ID: 14248813 [No Abstract] [Full Text] [Related]
58. ISOLATION OF THE TRIC AGENT FROM EYE AND UROGENITAL TRACT OF TRACHOMA PATIENTS IN DENMARK. MORDHORST CH Acta Pathol Microbiol Scand; 1965; 63():637-8. PubMed ID: 14330311 [No Abstract] [Full Text] [Related]
59. TRIC infections of the ocular, ENT and urogenital systems in whites. Scott JG S Afr Med J; 1968 Sep; 42(35):928-30. PubMed ID: 5687810 [No Abstract] [Full Text] [Related]
60. Isolation of Bedsoniae from human arthritis and abortion tissues. Schachter J Am J Ophthalmol; 1967 May; 63(5):Suppl:1082-6. PubMed ID: 6067306 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]